Strides Shasun Ltd., which has been shifting gears to become a global business-to-consumer operation from being almost an entirely business-to-business company, has bought the Australian operations of Amneal Pharmaceuticals, pursuing its goal of being the leading player in the Australian generics market.
The purchase for AUD17m ($13m) was made by Arrow Pharmaceuticals, a unit of Strides Pharma Global Pte Ltd in Singapore,...
Welcome to Scrip
Create an account to read this article
Already a subscriber?